Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Midurethral Sling Versus Cross-linked Hyaluronic Acid/dextranomer (CLHA/Dx) for the Treatment of Stress Urinary Incontinence

NCT06606613 is registered in ClinicalTrials.gov with Izmir Bakircay University as lead sponsor.

NCT NCT06606613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06606613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Midurethral Sling Versus Cross-linked Hyaluronic Acid/dextranomer (CLHA/Dx) for the Treatment of Stress Urinary Incontinence
Lead sponsor
Izmir Bakircay University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 10, 2024
Completion date
April 10, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urinary stress incontinence (si)